
Mesa Laboratories
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $60,138 | $63,724 | $65,126 | $60,737 |
Gross Profit | 39,012 | 46,650 | 41,795 | 37,331 |
EBITDA | 12,361 | 4,157 | 13,347 | 10,710 |
EBIT | 6,716 | -1,593 | 7,632 | 4,861 |
Net Income | 2,830 | -4,136 | 3,630 | 2,476 |
Net Change In Cash | 60,138 | 63,724 | 65,126 | 60,737 |
Free Cash Flow | 14,177 | 16,795 | 18,022 | 7,130 |
Cash | 30,695 | 26,928 | 28,975 | 20,422 |
Basic Shares | 5,757 | 5,544 | 5,565 | 5,535 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $249,130 | $240,978 | $216,187 | $219,080 |
Gross Profit | 158,270 | 150,870 | 133,250 | 133,693 |
EBITDA | 35,285 | 42,347 | -238,377 | 37,515 |
EBIT | 12,014 | 17,820 | -269,951 | 4,381 |
Net Income | 6,712 | -1,974 | -254,246 | 930 |
Net Change In Cash | 249,130 | 240,978 | 216,187 | 219,080 |
Cost of Revenue | -14,839 | |||
Free Cash Flow | 39,581 | 42,309 | 41,566 | 23,439 |
Cash | 26,928 | 27,321 | 28,214 | 32,910 |
Basic Shares | 5,565 | 5,429 | 5,386 | 5,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $2.21 |
2026-03-31 | $1.82 |
2025-12-31 | $1.76 |
2025-09-30 | $2.11 |